Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pfizer synthesizes new sodium channel blockers

July 16, 2013

Biogen presents in vivo and phase I pharmacokinetic results for BIIB-037

July 16, 2013

Dart Therapeutics begins phase Ib/IIa study of HT-100

July 16, 2013

Intellipharmaceutics provides updates on Rexista oxycodone technology development

July 16, 2013

Clinical data presented on Upsher-Smith's drug formulations for epilepsy

July 16, 2013

Novel potassium channel opener discovered at SciFluor Life Sciences

July 16, 2013

Promising first data for AbbVie compound in mild to moderate Alzheimer's disease

July 15, 2013

FDA and EMA issue decisions regarding C-Path's trial simulation tool for Alzheimer's disease

July 15, 2013

Diazepam nasal spray shows safety and bioavailability comparable to marketed rectal gel formulation

July 15, 2013

Allergan patents novel prostanoid receptor antagonists

July 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...